Fifth Third Bancorp
ALDR

Fifth Third Bancorp’s Alder Biopharmaceuticals ALDR Stock Holding History

Fifth Third Bancorp’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,276
Closed -$27K – 2304
2017
Q1 		$27K Buy
1,276
+185
+17% +$4.09K ﹤0.01% 1491
2016
Q4 		$23K Sell
1,091
-836
-43% -$21.7K ﹤0.01% 1584
2016
Q3 		$63K Buy
1,927
+427
+28% +$13K ﹤0.01% 1245
2016
Q2 		$37K Buy
+1,500
New +$40.6K ﹤0.01% 1398
2015
Q4 		– Sell
-25
Closed -$1K – 2963
2015
Q3 		$1K Buy
+25
New +$1.06K ﹤0.01% 2831

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Fifth Third Bancorp's ALDR Position: Q2 2017 in Review

Fifth Third Bancorp sold out of Alder Biopharmaceuticals (ALDR) in Q2 2017, closing a stake of 1,276 shares — an estimated $27K sold.

Fifth Third Bancorp first reported a position in ALDR in Q3 2015 and held it in 5 quarters. The position peaked at $63K in Q3 2016. 128 funds tracked by Wall St. Rank hold ALDR as of Q2 2017.

  • Fifth Third Bancorp reported no remaining Alder Biopharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Fifth Third Bancorp sold 1,276 Alder Biopharmaceuticals shares in Q2 2017, an estimated $27K.
  • Fifth Third Bancorp first reported a position in Alder Biopharmaceuticals in Q3 2015 and held it in 5 quarters.
  • Fifth Third Bancorp's Alder Biopharmaceuticals position peaked at $63K in Q3 2016.
  • 128 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q2 2017.

Based on Fifth Third Bancorp's 13F filing for Q2 2017, filed 11 Aug 2017.